Cargando…
Human Tumour Immune Evasion via TGF-β Blocks NK Cell Activation but Not Survival Allowing Therapeutic Restoration of Anti-Tumour Activity
Immune evasion is now recognized as a key feature of cancer progression. In animal models, the activity of cytotoxic lymphocytes is suppressed in the tumour microenvironment by the immunosuppressive cytokine, Transforming Growth Factor (TGF)-β. Release from TGF-β-mediated inhibition restores anti-tu...
Autores principales: | Wilson, Erica B., El-Jawhari, Jehan J., Neilson, Abbie L., Hall, Geoffrey D., Melcher, Alan A., Meade, Josephine L., Cook, Graham P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3167809/ https://www.ncbi.nlm.nih.gov/pubmed/21909397 http://dx.doi.org/10.1371/journal.pone.0022842 |
Ejemplares similares
-
Tumour Derived Extracellular Vesicles: Challenging Target to Blunt Tumour Immune Evasion
por: Lopatina, Tatiana, et al.
Publicado: (2022) -
The role of integrins in TGFβ activation in the tumour stroma
por: Khan, Zareen, et al.
Publicado: (2016) -
Integrin-Mediated TGFβ Activation Modulates the Tumour Microenvironment
por: Brown, Nicholas F., et al.
Publicado: (2019) -
MHC class II antigen presentation pathway in murine tumours: tumour evasion from immunosurveillance?
por: Walter, W, et al.
Publicado: (2000) -
Emerging role of PTEN loss in evasion of the immune response to tumours
por: Vidotto, Thiago, et al.
Publicado: (2020)